About Index Trending news
Analyze
Top 50 Pricing
Sharp Edge Labs

Sharp Edge Labs

Work at Sharp Edge Labs? Add yourself to this profile

Sharp Edge Labs

Sharp Edge Labs is developing next generation biosensors based on the Fluorogen Activating Peptide technology of co-Founders Alan Waggoner and Marcel Bruchez

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series B)
$600,000
Employees

Team size

2
Locations

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Sharp Edge Labs makes some noise.